# Soybean Oil

## Lipofundin (小兒TPN用100mL 20%)

| 藥物代碼           | ILIP21                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | In parenteral nutrition for energy & essential fatty acids.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| 副作用             | Adverse reactions directly related to fat emulsions in general are of 2 types: Immediate (Acute) Reactions: Dyspnea, cyanosis, allergic reactions, hyperlipaemia, hypercoagulability, nausea, vomiting, headache, flushing, hyperthermia, sweating, chills, sleepiness, chest and back pain.Delayed Reactions: Hepatomegaly, jaundice due to central lobular cholestasis, splenomegaly, thrombocytopenia, leucopenia, transient increases in liver function tests and overloading syndrome. The deposition of a brown pigmentation in the reticuloendothelial system, the so-called "IV Fat Pigment", has also been reported. The cause and the significance of this phenomenon are unknown. |
| 禁忌               | Disturbances in fat metabolism; ketoacidosis, hypoxia, thromboembolism & acute shock states.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 藥物保存方式       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 用法用量           | Adult 1-2 g of fat/kg/day by IV infusion. Infusion rate of 1st 15 mins should not exceed 0.05-1.0 g/kg/hr. Max infusion rate up to 0.15 g/kg/hr.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 肝功能異常         | 無需調整劑量  若成年人的血漿三酸甘油酯濃度超過3 mmol/L ,建議降低輸注速率或停止輸注 若兒童的血漿三酸甘油酯濃度超過1.7 mmol/L ,建議降低輸注速率或停止輸注                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 懷孕用藥危分級     | 尚未確立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 孕期用藥建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 哺乳期用藥建議     | Unknown 尚未建立                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 注射劑給藥建議途徑 | IVD                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| IVD 用法建議       | 輸注的最初15分鐘不宜超過每小時每公斤體重0.05 – 0.1 g 脂肪量，相當於0.25 – 0.5 ml/kg/hr。 最大輸注速率 ：每小時每公斤體重不大於 0.15 g 脂肪量，相當於0.75 mL/kg/hr 最大滴注速率 ：每分鐘每公斤體重不超過0.25滴。( 0.25 gtt/kg/min ) 以體重70公斤的病患為例，最大輸注速率為每小時50 ml或每分鐘18滴。 每日劑量的建議輸注速率不可少於16小時，較好的輸注時間為連續輸注24小時。                                                                                                                                                                                                                                                                                                                    |
| 注意事項           | 脂肪乳劑應以慢速輸注為原則。 營養不量患者及兒童應調降輸注速率。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

